

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin biosynthetic process (GO:0042438) | 5.97032985 |
| 2 | melanin metabolic process (GO:0006582) | 5.82126194 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.31181767 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.31181767 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.97451762 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78848408 |
| 7 | secondary metabolite biosynthetic process (GO:0044550) | 4.77273562 |
| 8 | developmental pigmentation (GO:0048066) | 4.60441387 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.55016851 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52494016 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.82012892 |
| 12 | detection of other organism (GO:0098543) | 3.66959458 |
| 13 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.62421099 |
| 14 | detection of bacterium (GO:0016045) | 3.61370095 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.60074776 |
| 16 | positive T cell selection (GO:0043368) | 3.57855219 |
| 17 | negative T cell selection (GO:0043383) | 3.49731900 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.42704628 |
| 19 | mannose metabolic process (GO:0006013) | 3.39136412 |
| 20 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37369438 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.31926027 |
| 22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.27713056 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 3.27687383 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25688608 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23097552 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16630126 |
| 27 | T cell selection (GO:0045058) | 3.15399172 |
| 28 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.15285251 |
| 29 | thymic T cell selection (GO:0045061) | 3.13140647 |
| 30 | cellular extravasation (GO:0045123) | 3.11926702 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.11626654 |
| 32 | regulation of ARF protein signal transduction (GO:0032012) | 3.04548812 |
| 33 | synaptic vesicle maturation (GO:0016188) | 3.00467437 |
| 34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.00283101 |
| 35 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.97851661 |
| 36 | neuronal action potential propagation (GO:0019227) | 2.97731819 |
| 37 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.94655511 |
| 38 | interferon-gamma production (GO:0032609) | 2.91749536 |
| 39 | signal complex assembly (GO:0007172) | 2.89971108 |
| 40 | activated T cell proliferation (GO:0050798) | 2.89410053 |
| 41 | detection of external biotic stimulus (GO:0098581) | 2.88837564 |
| 42 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.87521724 |
| 43 | sodium ion export (GO:0071436) | 2.85613255 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 2.82295314 |
| 45 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.81645453 |
| 46 | response to interleukin-15 (GO:0070672) | 2.80354295 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 2.77185651 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74800570 |
| 49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.74324782 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73825249 |
| 51 | L-amino acid import (GO:0043092) | 2.73419492 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 2.73211199 |
| 53 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.72649397 |
| 54 | regulation of tolerance induction (GO:0002643) | 2.72625871 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.71399184 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 2.69935018 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 2.68567820 |
| 58 | response to peptidoglycan (GO:0032494) | 2.67240205 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 2.66966953 |
| 60 | regulation of regulatory T cell differentiation (GO:0045589) | 2.65275090 |
| 61 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.62892671 |
| 62 | synaptic vesicle exocytosis (GO:0016079) | 2.61281684 |
| 63 | regulation of regulated secretory pathway (GO:1903305) | 2.59876208 |
| 64 | T cell migration (GO:0072678) | 2.58594988 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.58098716 |
| 66 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.56790107 |
| 67 | detection of biotic stimulus (GO:0009595) | 2.56324874 |
| 68 | T cell receptor signaling pathway (GO:0050852) | 2.55888751 |
| 69 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.55778603 |
| 70 | negative regulation of phagocytosis (GO:0050765) | 2.54195590 |
| 71 | potassium ion import (GO:0010107) | 2.53782630 |
| 72 | mast cell degranulation (GO:0043303) | 2.53303233 |
| 73 | mast cell activation involved in immune response (GO:0002279) | 2.53303233 |
| 74 | Golgi to endosome transport (GO:0006895) | 2.52254509 |
| 75 | locomotory exploration behavior (GO:0035641) | 2.52134561 |
| 76 | macrophage activation (GO:0042116) | 2.52103429 |
| 77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.51767200 |
| 78 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.51695376 |
| 79 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.51622917 |
| 80 | mast cell activation (GO:0045576) | 2.50785925 |
| 81 | histone H3-K4 trimethylation (GO:0080182) | 2.50349407 |
| 82 | nerve growth factor signaling pathway (GO:0038180) | 2.49844055 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.48336076 |
| 84 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.48061270 |
| 85 | negative regulation of interleukin-6 production (GO:0032715) | 2.46701027 |
| 86 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.46394062 |
| 87 | respiratory burst (GO:0045730) | 2.46221176 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.45384187 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45351526 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.45211214 |
| 91 | response to type I interferon (GO:0034340) | 2.43313722 |
| 92 | negative regulation of type 2 immune response (GO:0002829) | 2.41987411 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.41802510 |
| 94 | negative regulation of T cell mediated immunity (GO:0002710) | 2.41537033 |
| 95 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.41110754 |
| 96 | positive regulation of granulocyte differentiation (GO:0030854) | 2.40800703 |
| 97 | vocalization behavior (GO:0071625) | 2.40652384 |
| 98 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.40435887 |
| 99 | leukocyte aggregation (GO:0070486) | 2.40119132 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.39196240 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.39031175 |
| 102 | cellular response to type I interferon (GO:0071357) | 2.39031175 |
| 103 | tolerance induction (GO:0002507) | 2.38310567 |
| 104 | regulation of B cell differentiation (GO:0045577) | 2.38132778 |
| 105 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.37426300 |
| 106 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.37426300 |
| 107 | neutrophil mediated immunity (GO:0002446) | 2.37425158 |
| 108 | synaptic vesicle endocytosis (GO:0048488) | 2.37203430 |
| 109 | long-term memory (GO:0007616) | 2.37115857 |
| 110 | positive regulation of histone deacetylation (GO:0031065) | 2.36305639 |
| 111 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.35975338 |
| 112 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35975338 |
| 113 | modulation by symbiont of host immune response (GO:0052553) | 2.35975338 |
| 114 | positive regulation by symbiont of host defense response (GO:0052509) | 2.35975338 |
| 115 | modulation by symbiont of host defense response (GO:0052031) | 2.35975338 |
| 116 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35975338 |
| 117 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35525271 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.35430167 |
| 119 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.34348555 |
| 120 | detection of molecule of bacterial origin (GO:0032490) | 2.34336278 |
| 121 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.33878208 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.33506962 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 2.32340494 |
| 124 | T cell homeostasis (GO:0043029) | 2.31873073 |
| 125 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.31298611 |
| 126 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.30550240 |
| 127 | response to pheromone (GO:0019236) | 2.30485359 |
| 128 | regulation of synapse structural plasticity (GO:0051823) | 2.30014314 |
| 129 | germinal center formation (GO:0002467) | 2.30008521 |
| 130 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.28371323 |
| 131 | protein localization to synapse (GO:0035418) | 2.28045493 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 2.27584113 |
| 133 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.26699111 |
| 134 | neutrophil activation (GO:0042119) | 2.26414574 |
| 135 | microglial cell activation (GO:0001774) | 2.26344091 |
| 136 | myeloid leukocyte mediated immunity (GO:0002444) | 2.26080321 |
| 137 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.26070554 |
| 138 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.25758037 |
| 139 | regulation of ARF GTPase activity (GO:0032312) | 2.25007637 |
| 140 | pigmentation (GO:0043473) | 2.24564944 |
| 141 | adult walking behavior (GO:0007628) | 2.24476500 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.24271505 |
| 143 | positive regulation of Rap GTPase activity (GO:0032854) | 2.24169938 |
| 144 | response to muramyl dipeptide (GO:0032495) | 2.24089054 |
| 145 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.23680873 |
| 146 | synaptic transmission, glutamatergic (GO:0035249) | 2.21914642 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.20388293 |
| 148 | protein kinase C signaling (GO:0070528) | 2.18984658 |
| 149 | membrane depolarization during action potential (GO:0086010) | 2.18679711 |
| 150 | T cell mediated immunity (GO:0002456) | 2.18118680 |
| 151 | amino acid import (GO:0043090) | 2.15230729 |
| 152 | potassium ion homeostasis (GO:0055075) | 2.14245249 |
| 153 | regulation of Rap GTPase activity (GO:0032317) | 2.13881258 |
| 154 | T cell costimulation (GO:0031295) | 2.13859159 |
| 155 | positive regulation of tolerance induction (GO:0002645) | 2.13220852 |
| 156 | activation of protein kinase A activity (GO:0034199) | 2.11610252 |
| 157 | lymphocyte costimulation (GO:0031294) | 2.11069247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.65501313 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35649021 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.23439063 |
| 4 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.65649092 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39844922 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39377684 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.37838235 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.15594917 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10681411 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.09682620 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04336758 |
| 12 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03775443 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97168392 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.96917791 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92502473 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88918255 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.87284495 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83822900 |
| 19 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.76829846 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.76398509 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76166040 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.75546473 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73034413 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71378021 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.69935061 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 1.69565743 |
| 27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68240823 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.68158919 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66288922 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66193764 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66113472 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65645713 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65645713 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63820195 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63390180 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61545199 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53755939 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50090375 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45834279 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45741389 |
| 41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45617960 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45430983 |
| 43 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43072319 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43002383 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42215818 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41339747 |
| 47 | P68_20966046_ChIP-Seq_HELA_Human | 1.39617692 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38619517 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38484188 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38364698 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36858783 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35532682 |
| 53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35325905 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34808761 |
| 55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34194582 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30716524 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.29792288 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29488497 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29145201 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28550131 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27825429 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26141407 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25331200 |
| 64 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.25006966 |
| 65 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23816266 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23367354 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22277022 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20111155 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19671952 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19256177 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19141248 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19008817 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18661677 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17404502 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17091097 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16955986 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16213541 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15843307 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14653709 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13891201 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13413635 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13221119 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.13021210 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12927389 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12871587 |
| 86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12336669 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11763389 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10027606 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09723218 |
| 90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09670426 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09019934 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08860451 |
| 93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08448425 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08238640 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07749330 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07686673 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07215116 |
| 98 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06121962 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05701851 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05234089 |
| 101 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04894474 |
| 102 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04111485 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03144477 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02679712 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02652834 |
| 106 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.02622978 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02373621 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02302904 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 1.01734264 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01406624 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00904897 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00823432 |
| 113 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00782218 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00765495 |
| 115 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00748979 |
| 116 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00576445 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00441397 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00357009 |
| 119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99932524 |
| 120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99285808 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99081502 |
| 122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98206495 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98072649 |
| 124 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97750925 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96995165 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95256633 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94184725 |
| 128 | SA1_27219007_Chip-Seq_Bcells_Human | 0.93620486 |
| 129 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93139431 |
| 130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92842351 |
| 131 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.92423902 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92308008 |
| 133 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91697854 |
| 134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91164808 |
| 135 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90076884 |
| 136 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89087434 |
| 137 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88969754 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88739612 |
| 139 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84506976 |
| 140 | MYB_26560356_Chip-Seq_TH1_Human | 0.84153681 |
| 141 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82768474 |
| 142 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81679306 |
| 143 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81027389 |
| 144 | AR_19668381_ChIP-Seq_PC3_Human | 0.81011332 |
| 145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79803767 |
| 146 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79797115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.32247468 |
| 2 | MP0000372_irregular_coat_pigmentation | 4.01811796 |
| 3 | MP0005171_absent_coat_pigmentation | 3.35861919 |
| 4 | MP0000015_abnormal_ear_pigmentation | 3.34820169 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.26052521 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.18817761 |
| 7 | MP0004381_abnormal_hair_follicle | 2.97360396 |
| 8 | MP0004510_myositis | 2.48220062 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.29189919 |
| 10 | MP0000371_diluted_coat_color | 2.26156448 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.25724466 |
| 12 | MP0009046_muscle_twitch | 2.22068449 |
| 13 | MP0008260_abnormal_autophagy | 2.05960542 |
| 14 | MP0003880_abnormal_central_pattern | 2.00543052 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 1.98193251 |
| 16 | MP0005409_darkened_coat_color | 1.96487537 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.89258773 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 1.86380905 |
| 19 | MP0002095_abnormal_skin_pigmentation | 1.83197751 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.81941316 |
| 21 | MP0008569_lethality_at_weaning | 1.81495030 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.79312318 |
| 23 | MP0003136_yellow_coat_color | 1.74402892 |
| 24 | MP0002064_seizures | 1.73854116 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.68299502 |
| 26 | MP0005671_abnormal_response_to | 1.65369016 |
| 27 | MP0002933_joint_inflammation | 1.64040583 |
| 28 | MP0003329_amyloid_beta_deposits | 1.64039175 |
| 29 | MP0009745_abnormal_behavioral_response | 1.63565512 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.62560931 |
| 31 | MP0005408_hypopigmentation | 1.62273975 |
| 32 | MP0009278_abnormal_bone_marrow | 1.59349458 |
| 33 | MP0000685_abnormal_immune_system | 1.54098561 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.53467081 |
| 35 | MP0003828_pulmonary_edema | 1.52349631 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.50062226 |
| 37 | MP0005387_immune_system_phenotype | 1.49698262 |
| 38 | MP0001790_abnormal_immune_system | 1.49698262 |
| 39 | MP0003279_aneurysm | 1.46923301 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.45962990 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.45136451 |
| 42 | MP0003303_peritoneal_inflammation | 1.40381466 |
| 43 | MP0002272_abnormal_nervous_system | 1.38072595 |
| 44 | MP0001800_abnormal_humoral_immune | 1.37079712 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.36623870 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.35899571 |
| 47 | MP0005310_abnormal_salivary_gland | 1.35588522 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.33329380 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.31035519 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.30527314 |
| 51 | MP0002063_abnormal_learning/memory/cond | 1.30464896 |
| 52 | MP0002723_abnormal_immune_serum | 1.30344937 |
| 53 | MP0001819_abnormal_immune_cell | 1.30035273 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.28043673 |
| 55 | MP0002419_abnormal_innate_immunity | 1.27278934 |
| 56 | MP0004130_abnormal_muscle_cell | 1.27174982 |
| 57 | MP0002075_abnormal_coat/hair_pigmentati | 1.27113434 |
| 58 | MP0001873_stomach_inflammation | 1.24541612 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.23920736 |
| 60 | MP0001486_abnormal_startle_reflex | 1.23873176 |
| 61 | MP0002572_abnormal_emotion/affect_behav | 1.23146784 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.21877847 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.21320830 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.19742135 |
| 65 | MP0000920_abnormal_myelination | 1.18838544 |
| 66 | MP0009840_abnormal_foam_cell | 1.18123321 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.17944739 |
| 68 | MP0005451_abnormal_body_composition | 1.16353328 |
| 69 | MP0004742_abnormal_vestibular_system | 1.15347749 |
| 70 | MP0002735_abnormal_chemical_nociception | 1.13591755 |
| 71 | MP0006082_CNS_inflammation | 1.13380702 |
| 72 | MP0004858_abnormal_nervous_system | 1.12876941 |
| 73 | MP0001324_abnormal_eye_pigmentation | 1.10674412 |
| 74 | MP0002722_abnormal_immune_system | 1.09685349 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 1.07954567 |
| 76 | MP0002429_abnormal_blood_cell | 1.07949136 |
| 77 | MP0004883_abnormal_blood_vessel | 1.07564975 |
| 78 | MP0005025_abnormal_response_to | 1.07467402 |
| 79 | MP0005670_abnormal_white_adipose | 1.06650735 |
| 80 | MP0003633_abnormal_nervous_system | 1.06029189 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.05660257 |
| 82 | MP0003866_abnormal_defecation | 1.05474455 |
| 83 | MP0002090_abnormal_vision | 1.05316914 |
| 84 | MP0004270_analgesia | 1.05140032 |
| 85 | MP0003436_decreased_susceptibility_to | 1.04007761 |
| 86 | MP0003075_altered_response_to | 1.03564081 |
| 87 | MP0003091_abnormal_cell_migration | 1.03485860 |
| 88 | MP0002638_abnormal_pupillary_reflex | 1.02444018 |
| 89 | MP0005464_abnormal_platelet_physiology | 1.02251353 |
| 90 | MP0004885_abnormal_endolymph | 1.02136049 |
| 91 | MP0002006_tumorigenesis | 1.01853763 |
| 92 | MP0005551_abnormal_eye_electrophysiolog | 1.00705885 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.99605022 |
| 94 | MP0001663_abnormal_digestive_system | 0.98558561 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.98415531 |
| 96 | MP0008874_decreased_physiological_sensi | 0.97246984 |
| 97 | MP0002736_abnormal_nociception_after | 0.96372592 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.94191187 |
| 99 | MP0005386_behavior/neurological_phenoty | 0.93411951 |
| 100 | MP0004924_abnormal_behavior | 0.93411951 |
| 101 | MP0008469_abnormal_protein_level | 0.92672563 |
| 102 | MP0002398_abnormal_bone_marrow | 0.92392586 |
| 103 | MP0003787_abnormal_imprinting | 0.92181494 |
| 104 | MP0003634_abnormal_glial_cell | 0.91797219 |
| 105 | MP0002184_abnormal_innervation | 0.91331598 |
| 106 | MP0001186_pigmentation_phenotype | 0.90997008 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.90344406 |
| 108 | MP0003724_increased_susceptibility_to | 0.90160013 |
| 109 | MP0003690_abnormal_glial_cell | 0.90067111 |
| 110 | MP0000716_abnormal_immune_system | 0.90018092 |
| 111 | MP0001970_abnormal_pain_threshold | 0.89488779 |
| 112 | MP0000703_abnormal_thymus_morphology | 0.88911182 |
| 113 | MP0005166_decreased_susceptibility_to | 0.88677707 |
| 114 | MP0002405_respiratory_system_inflammati | 0.88204224 |
| 115 | MP0000604_amyloidosis | 0.88100442 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.87607757 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.87466802 |
| 118 | MP0001440_abnormal_grooming_behavior | 0.86794385 |
| 119 | MP0002557_abnormal_social/conspecific_i | 0.85774176 |
| 120 | MP0003045_fibrosis | 0.85464103 |
| 121 | MP0000249_abnormal_blood_vessel | 0.84596366 |
| 122 | MP0001849_ear_inflammation | 0.83640724 |
| 123 | MP0002148_abnormal_hypersensitivity_rea | 0.82723009 |
| 124 | MP0003879_abnormal_hair_cell | 0.81944393 |
| 125 | MP0002229_neurodegeneration | 0.81431540 |
| 126 | MP0005390_skeleton_phenotype | 0.80917000 |
| 127 | MP0004947_skin_inflammation | 0.80855849 |
| 128 | MP0002132_abnormal_respiratory_system | 0.80583767 |
| 129 | MP0001851_eye_inflammation | 0.80425438 |
| 130 | MP0000767_abnormal_smooth_muscle | 0.80190004 |
| 131 | MP0009785_altered_susceptibility_to | 0.79752496 |
| 132 | MP0000858_altered_metastatic_potential | 0.79626539 |
| 133 | MP0009764_decreased_sensitivity_to | 0.79216812 |
| 134 | MP0001348_abnormal_lacrimal_gland | 0.78826397 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.74647162 |
| 136 | MP0001958_emphysema | 0.73759087 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.73746303 |
| 138 | MP0000778_abnormal_nervous_system | 0.73580172 |
| 139 | MP0002822_catalepsy | 0.73113314 |
| 140 | MP0002396_abnormal_hematopoietic_system | 0.72572852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ocular albinism (HP:0001107) | 5.02724590 |
| 2 | Iris hypopigmentation (HP:0007730) | 4.49610871 |
| 3 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.06835151 |
| 4 | Stomatitis (HP:0010280) | 4.05853111 |
| 5 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.85282986 |
| 6 | Blue irides (HP:0000635) | 3.75271518 |
| 7 | Generalized hypopigmentation (HP:0007513) | 3.69871023 |
| 8 | Spontaneous hematomas (HP:0007420) | 3.69400551 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.56167571 |
| 10 | Obstructive sleep apnea (HP:0002870) | 3.55129693 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.34064000 |
| 12 | Focal motor seizures (HP:0011153) | 3.29611297 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25933963 |
| 14 | Febrile seizures (HP:0002373) | 3.20268119 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.19471302 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.17170105 |
| 17 | Papilledema (HP:0001085) | 3.16185070 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.12171320 |
| 19 | Pustule (HP:0200039) | 3.10697151 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.07217242 |
| 21 | Hypoplasia of the fovea (HP:0007750) | 3.06066298 |
| 22 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.06066298 |
| 23 | Increased IgE level (HP:0003212) | 3.01254040 |
| 24 | Diplopia (HP:0000651) | 2.98679036 |
| 25 | Abnormality of binocular vision (HP:0011514) | 2.98679036 |
| 26 | T lymphocytopenia (HP:0005403) | 2.91989803 |
| 27 | Cellulitis (HP:0100658) | 2.90107279 |
| 28 | Focal seizures (HP:0007359) | 2.86875529 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 2.84524628 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80487327 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80487327 |
| 32 | Abnormality of T cell number (HP:0011839) | 2.78904640 |
| 33 | Visual hallucinations (HP:0002367) | 2.77743600 |
| 34 | Recurrent bacterial skin infections (HP:0005406) | 2.77519192 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.73838205 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64620713 |
| 37 | Recurrent fungal infections (HP:0002841) | 2.63533366 |
| 38 | Hemiplegia (HP:0002301) | 2.63193444 |
| 39 | Abnormality of the fovea (HP:0000493) | 2.58957234 |
| 40 | Albinism (HP:0001022) | 2.57016367 |
| 41 | Action tremor (HP:0002345) | 2.56606230 |
| 42 | Encephalitis (HP:0002383) | 2.55899815 |
| 43 | Loss of speech (HP:0002371) | 2.50820284 |
| 44 | Vasculitis (HP:0002633) | 2.50628079 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.50557376 |
| 46 | Atonic seizures (HP:0010819) | 2.49064899 |
| 47 | Cerebral aneurysm (HP:0004944) | 2.47630563 |
| 48 | Chest pain (HP:0100749) | 2.46680991 |
| 49 | Broad face (HP:0000283) | 2.45065829 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.42384851 |
| 51 | Epileptic encephalopathy (HP:0200134) | 2.39875744 |
| 52 | Colitis (HP:0002583) | 2.39353927 |
| 53 | Myokymia (HP:0002411) | 2.38865460 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.38283579 |
| 55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.38283579 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.38283579 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.37468599 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.36037557 |
| 59 | Slow saccadic eye movements (HP:0000514) | 2.34892905 |
| 60 | Genetic anticipation (HP:0003743) | 2.34725173 |
| 61 | Abnormality of the fingertips (HP:0001211) | 2.34308873 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.33450186 |
| 63 | Ankle clonus (HP:0011448) | 2.31673045 |
| 64 | Episodic fever (HP:0001954) | 2.31287347 |
| 65 | Myositis (HP:0100614) | 2.31074182 |
| 66 | Hypochromic anemia (HP:0001931) | 2.30021806 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.25684776 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25214333 |
| 69 | Amyloidosis (HP:0011034) | 2.24291421 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.22402407 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.21841442 |
| 72 | Peritonitis (HP:0002586) | 2.19744341 |
| 73 | Congenital stationary night blindness (HP:0007642) | 2.19737902 |
| 74 | Recurrent skin infections (HP:0001581) | 2.19188092 |
| 75 | Dysmetria (HP:0001310) | 2.18486139 |
| 76 | Epistaxis (HP:0000421) | 2.18441313 |
| 77 | Gingivitis (HP:0000230) | 2.15214339 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.14066243 |
| 79 | Optic neuritis (HP:0100653) | 2.14066243 |
| 80 | Truncal ataxia (HP:0002078) | 2.12305856 |
| 81 | Thin bony cortex (HP:0002753) | 2.09192045 |
| 82 | Keratoconjunctivitis (HP:0001096) | 2.08478903 |
| 83 | Pulmonary embolism (HP:0002204) | 2.07942748 |
| 84 | Thyroiditis (HP:0100646) | 2.07419703 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07384848 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07384848 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07384848 |
| 88 | Dysmetric saccades (HP:0000641) | 2.06904044 |
| 89 | Autoimmune thrombocytopenia (HP:0001973) | 2.06399683 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06126529 |
| 91 | Frequent falls (HP:0002359) | 2.06049114 |
| 92 | Abnormality of the nasal mucosa (HP:0000433) | 2.04516441 |
| 93 | Progressive inability to walk (HP:0002505) | 2.04099476 |
| 94 | Absence seizures (HP:0002121) | 2.03848217 |
| 95 | Panhypogammaglobulinemia (HP:0003139) | 2.03617546 |
| 96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01852653 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.01619149 |
| 98 | Neurofibrillary tangles (HP:0002185) | 2.00874898 |
| 99 | Hematochezia (HP:0002573) | 1.99876448 |
| 100 | Severe combined immunodeficiency (HP:0004430) | 1.99808463 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 1.99506059 |
| 102 | Abnormality of vision evoked potentials (HP:0000649) | 1.99138214 |
| 103 | Congenital sensorineural hearing impairment (HP:0008527) | 1.98904899 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 1.98848426 |
| 105 | Generalized hypopigmentation of hair (HP:0011358) | 1.98063066 |
| 106 | Broad-based gait (HP:0002136) | 1.97496944 |
| 107 | Scanning speech (HP:0002168) | 1.97411714 |
| 108 | Papilloma (HP:0012740) | 1.97204819 |
| 109 | Verrucae (HP:0200043) | 1.97204819 |
| 110 | Spinal canal stenosis (HP:0003416) | 1.95612295 |
| 111 | Hemiparesis (HP:0001269) | 1.94913346 |
| 112 | Agammaglobulinemia (HP:0004432) | 1.94696406 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92284151 |
| 114 | Obstructive lung disease (HP:0006536) | 1.92284151 |
| 115 | Impaired smooth pursuit (HP:0007772) | 1.90810360 |
| 116 | Dialeptic seizures (HP:0011146) | 1.90327643 |
| 117 | Acne (HP:0001061) | 1.89788638 |
| 118 | Leukocytosis (HP:0001974) | 1.89656531 |
| 119 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.89061608 |
| 120 | J-shaped sella turcica (HP:0002680) | 1.88675835 |
| 121 | Mask-like facies (HP:0000298) | 1.88079266 |
| 122 | Abnormality of saccadic eye movements (HP:0000570) | 1.87853157 |
| 123 | Chronic otitis media (HP:0000389) | 1.87384455 |
| 124 | Depression (HP:0000716) | 1.87252160 |
| 125 | Onion bulb formation (HP:0003383) | 1.86575677 |
| 126 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.85868172 |
| 127 | Recurrent viral infections (HP:0004429) | 1.84481281 |
| 128 | Gingival bleeding (HP:0000225) | 1.83289665 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.81516607 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81516607 |
| 131 | Hypoplasia of the iris (HP:0007676) | 1.81384370 |
| 132 | Lymphopenia (HP:0001888) | 1.81249860 |
| 133 | Mutism (HP:0002300) | 1.81116235 |
| 134 | Interstitial pulmonary disease (HP:0006530) | 1.81097876 |
| 135 | Abnormality of the endocardium (HP:0004306) | 1.80800472 |
| 136 | Hemoptysis (HP:0002105) | 1.80109484 |
| 137 | Microcytic anemia (HP:0001935) | 1.79325050 |
| 138 | Cerebral inclusion bodies (HP:0100314) | 1.78382959 |
| 139 | Inflammation of the large intestine (HP:0002037) | 1.78279880 |
| 140 | Annular pancreas (HP:0001734) | 1.78261100 |
| 141 | Psychosis (HP:0000709) | 1.77646658 |
| 142 | Restrictive lung disease (HP:0002091) | 1.76896649 |
| 143 | Osteomyelitis (HP:0002754) | 1.76773583 |
| 144 | Rapidly progressive (HP:0003678) | 1.75776581 |
| 145 | Urticaria (HP:0001025) | 1.75213736 |
| 146 | Easy fatigability (HP:0003388) | 1.75047561 |
| 147 | Polygenic inheritance (HP:0010982) | 1.72760255 |
| 148 | Dysdiadochokinesis (HP:0002075) | 1.72609572 |
| 149 | Orchitis (HP:0100796) | 1.72598181 |
| 150 | Meningitis (HP:0001287) | 1.70883461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 2.92611785 |
| 2 | TXK | 2.86053127 |
| 3 | MAP3K13 | 2.82894611 |
| 4 | SIK2 | 2.77508005 |
| 5 | ERN1 | 2.73369762 |
| 6 | RIPK4 | 2.68538887 |
| 7 | FES | 2.46855494 |
| 8 | CAMKK2 | 2.45588930 |
| 9 | MST1R | 2.08857728 |
| 10 | CAMK1G | 1.97768451 |
| 11 | TNIK | 1.85726772 |
| 12 | SIK1 | 1.82358475 |
| 13 | MAP2K3 | 1.77906249 |
| 14 | PRPF4B | 1.77578787 |
| 15 | IKBKE | 1.77309262 |
| 16 | DAPK2 | 1.74219105 |
| 17 | JAK1 | 1.68600508 |
| 18 | MARK3 | 1.66905525 |
| 19 | CAMKK1 | 1.61140021 |
| 20 | ITK | 1.59083780 |
| 21 | KIT | 1.52887923 |
| 22 | PRKCH | 1.51985836 |
| 23 | MAP3K11 | 1.49329357 |
| 24 | ZAP70 | 1.48021731 |
| 25 | TYK2 | 1.47558407 |
| 26 | MAP3K14 | 1.45323825 |
| 27 | CAMK1D | 1.44583515 |
| 28 | TAOK1 | 1.43054332 |
| 29 | JAK3 | 1.40900836 |
| 30 | HCK | 1.37683654 |
| 31 | NTRK3 | 1.36338532 |
| 32 | CDC42BPA | 1.29019073 |
| 33 | PAK6 | 1.26621471 |
| 34 | TBK1 | 1.24648519 |
| 35 | IRAK3 | 1.18551516 |
| 36 | LCK | 1.18188747 |
| 37 | MARK2 | 1.18019440 |
| 38 | STK38 | 1.16770973 |
| 39 | NTRK2 | 1.15781154 |
| 40 | TNK2 | 1.14508188 |
| 41 | SYK | 1.13190198 |
| 42 | SMG1 | 1.13122386 |
| 43 | MAP3K3 | 1.05068374 |
| 44 | PRKD3 | 1.04949233 |
| 45 | MAP3K9 | 1.03096363 |
| 46 | SGK2 | 1.00885592 |
| 47 | RIPK1 | 0.99589779 |
| 48 | CAMK1 | 0.98459569 |
| 49 | TAOK3 | 0.97815898 |
| 50 | MAP3K10 | 0.97455268 |
| 51 | SGK3 | 0.97449055 |
| 52 | SIK3 | 0.97146105 |
| 53 | IRAK4 | 0.96209885 |
| 54 | PRKD2 | 0.95968276 |
| 55 | MAPK12 | 0.92785283 |
| 56 | NLK | 0.89289495 |
| 57 | PDK1 | 0.87720479 |
| 58 | SGK223 | 0.87219552 |
| 59 | SGK494 | 0.87219552 |
| 60 | CASK | 0.86396125 |
| 61 | WNK1 | 0.85750545 |
| 62 | EPHA4 | 0.85061881 |
| 63 | ICK | 0.84348622 |
| 64 | MAP2K7 | 0.83782393 |
| 65 | CDK5 | 0.83457373 |
| 66 | MAP3K7 | 0.83419906 |
| 67 | TIE1 | 0.83379189 |
| 68 | TTN | 0.82321684 |
| 69 | PKN1 | 0.80028812 |
| 70 | PRKCQ | 0.79628390 |
| 71 | HIPK2 | 0.78696923 |
| 72 | FGFR3 | 0.78626154 |
| 73 | FGFR4 | 0.78280071 |
| 74 | CSK | 0.78162683 |
| 75 | JAK2 | 0.76776863 |
| 76 | TGFBR2 | 0.76673812 |
| 77 | TEC | 0.76135652 |
| 78 | IKBKB | 0.76085665 |
| 79 | KSR2 | 0.75634033 |
| 80 | GRK6 | 0.75472006 |
| 81 | MAP3K4 | 0.75102168 |
| 82 | FYN | 0.74853483 |
| 83 | STK11 | 0.73182000 |
| 84 | PTK2B | 0.72384076 |
| 85 | CLK1 | 0.71972533 |
| 86 | CAMK4 | 0.71456542 |
| 87 | UHMK1 | 0.68543209 |
| 88 | TYRO3 | 0.68092382 |
| 89 | MAPK7 | 0.67741411 |
| 90 | DYRK1B | 0.67731969 |
| 91 | MAPK15 | 0.66631598 |
| 92 | BLK | 0.66563836 |
| 93 | FGR | 0.66132446 |
| 94 | PDPK1 | 0.65885864 |
| 95 | RPS6KA2 | 0.65132626 |
| 96 | BMX | 0.64824240 |
| 97 | PDGFRB | 0.63372737 |
| 98 | EPHA3 | 0.63363106 |
| 99 | SGK1 | 0.63182654 |
| 100 | PHKG2 | 0.62482455 |
| 101 | PHKG1 | 0.62482455 |
| 102 | CSF1R | 0.62431505 |
| 103 | CDK19 | 0.62099263 |
| 104 | PTK6 | 0.61263755 |
| 105 | PKN2 | 0.61096196 |
| 106 | DAPK1 | 0.59163255 |
| 107 | MARK1 | 0.57216213 |
| 108 | EPHB1 | 0.56785216 |
| 109 | MAP2K6 | 0.56641270 |
| 110 | MAP3K1 | 0.54725325 |
| 111 | TRIB3 | 0.53585528 |
| 112 | MAP3K6 | 0.50151744 |
| 113 | RPS6KL1 | 0.49769961 |
| 114 | RPS6KC1 | 0.49769961 |
| 115 | RET | 0.49755392 |
| 116 | IRAK1 | 0.49223501 |
| 117 | LYN | 0.48289484 |
| 118 | KDR | 0.47744987 |
| 119 | MUSK | 0.47711806 |
| 120 | PRKD1 | 0.47305768 |
| 121 | BTK | 0.47305630 |
| 122 | DAPK3 | 0.46114681 |
| 123 | MINK1 | 0.45310712 |
| 124 | MAPK11 | 0.44967439 |
| 125 | SRC | 0.44804105 |
| 126 | RPS6KA6 | 0.44507372 |
| 127 | DYRK1A | 0.42639539 |
| 128 | MAP3K12 | 0.42126462 |
| 129 | IRAK2 | 0.41486777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.97954677 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 1.94744127 |
| 3 | Morphine addiction_Homo sapiens_hsa05032 | 1.75336977 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70401935 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68893411 |
| 6 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.67119343 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.65784105 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60904964 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60753218 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60016897 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.58544367 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54553458 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54031446 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.52405903 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46474187 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41582820 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.41153143 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40430202 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.37245232 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35029656 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33532217 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.33124643 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28751734 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.26969314 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26639446 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24055925 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22570350 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18085162 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.17583095 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16841618 |
| 31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14883766 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14070325 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.13862663 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.12988320 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12310810 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11409370 |
| 37 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10869286 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.09979600 |
| 39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09410449 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08596518 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.07506819 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.06856377 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06731810 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.05667847 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04397230 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04299415 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01204813 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99892634 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99720126 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98796564 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97571990 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96863731 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96392385 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94704051 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94413705 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93172858 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92065524 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91832804 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91178088 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.90398256 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90343019 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89826416 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.87318733 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85773503 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84576606 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83978472 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.82632111 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82288499 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.81917708 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.81849150 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.81132985 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80665894 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.79557361 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79360507 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.78795595 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78773817 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.77614033 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77540337 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77265894 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77202523 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76973239 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.76966313 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76375452 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.75486352 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74224626 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73990084 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73626357 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73068011 |
| 89 | Pertussis_Homo sapiens_hsa05133 | 0.72926617 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72841299 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72183341 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71953619 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71946535 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71189677 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.70972881 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70941608 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70911876 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.70853063 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70795571 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70343925 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70339953 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69912739 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68702364 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67004805 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.66769519 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.65963226 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65919973 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65723223 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64817750 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.64551269 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64072316 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63070020 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62918247 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62459866 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.62386256 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62313294 |
| 117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61627530 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61572948 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61208765 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.60740669 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60669629 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60090587 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59338405 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59319957 |

